- Home
- IOVA vs AMN Comparison
IOVA vs AMN Comparison
Compare IOVA & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- AMN
- Stock Information
- Founded
- IOVA 2007
- AMN 1985
- Country
- IOVA United States
- AMN United States
- Employees
- IOVA N/A
- AMN N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- AMN Assisted Living Services
- Sector
- IOVA Health Care
- AMN Health Care
- Exchange
- IOVA Nasdaq
- AMN Nasdaq
- Market Cap
- IOVA 1.0B
- AMN 1.0B
- IPO Year
- IOVA N/A
- AMN 2001
- Fundamental
- Price
- IOVA $1.75
- AMN $22.01
- Analyst Decision
- IOVA Strong Buy
- AMN Hold
- Analyst Count
- IOVA 9
- AMN 8
- Target Price
- IOVA $15.50
- AMN $38.50
- AVG Volume (30 Days)
- IOVA 13.9M
- AMN 1.0M
- Earning Date
- IOVA 05-08-2025
- AMN 05-08-2025
- Dividend Yield
- IOVA N/A
- AMN N/A
- EPS Growth
- IOVA N/A
- AMN N/A
- EPS
- IOVA N/A
- AMN N/A
- Revenue
- IOVA $212,679,000.00
- AMN $2,852,436,000.00
- Revenue This Year
- IOVA $182.20
- AMN N/A
- Revenue Next Year
- IOVA $62.10
- AMN $2.89
- P/E Ratio
- IOVA N/A
- AMN N/A
- Revenue Growth
- IOVA 11070.12
- AMN N/A
- 52 Week Low
- IOVA $2.70
- AMN $17.45
- 52 Week High
- IOVA $13.60
- AMN $70.07
- Technical
- Relative Strength Index (RSI)
- IOVA 23.78
- AMN 58.82
- Support Level
- IOVA $3.02
- AMN $19.39
- Resistance Level
- IOVA $3.31
- AMN $21.28
- Average True Range (ATR)
- IOVA 0.24
- AMN 1.17
- MACD
- IOVA -0.09
- AMN 0.41
- Stochastic Oscillator
- IOVA 4.81
- AMN 72.65
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About AMN AMN Healthcare Services Inc
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.